-
1
-
-
68649110032
-
Mendelian forms of Parkinson's disease
-
Gasser T: Mendelian forms of Parkinson's disease. Biochim Biophys Acta 2009, 1792:587-596.
-
(2009)
Biochim Biophys Acta
, vol.1792
, pp. 587-596
-
-
Gasser, T.1
-
2
-
-
0032497504
-
Parkinson's disease
-
DOI 10.1056/NEJM199810083391506
-
Lang AE, Lozano AM: Parkinson's Disease. First of Two Parts. N Engl J Med 1998, 339:1044-1053. (Pubitemid 28457867)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.15
, pp. 1044-1053
-
-
Lang, A.E.1
Lozano, A.M.2
-
3
-
-
0032531924
-
Parkinson's disease: Second of two parts
-
DOI 10.1056/NEJM199810153391607
-
Lang AE, Lozano AM: Parkinson's disease. Second of Two Parts. N Engl J Med 1998, 339:1130-1143. (Pubitemid 28465762)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.16
, pp. 1130-1143
-
-
Lang, A.E.1
Lozano, A.M.2
-
4
-
-
8844266996
-
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
-
DOI 10.1016/j.neuron.2004.10.023, PII S0896627304006890
-
Paisán-Ruiz C, Jain S, Evans EW et al.: Cloning of the gene containing mutations that cause PARK8-linked Parkinson's Disease. Neuron 2004, 44:595-600. (Pubitemid 39531224)
-
(2004)
Neuron
, vol.44
, Issue.4
, pp. 595-600
-
-
Paisan-Ruiz, C.1
Jain, S.2
Evans, E.W.3
Gilks, W.P.4
Simon, J.5
Van Der Brug, M.6
De Munain, A.L.7
Aparicio, S.8
Gil, A.M.9
Khan, N.10
Johnson, J.11
Martinez, J.R.12
Nicholl, D.13
Carrera, I.M.14
Pena, A.S.15
De Silva, R.16
Lees, A.17
Marti-Masso, J.F.18
Perez-Tur, J.19
Wood, N.W.20
Singleton, A.B.21
more..
-
5
-
-
8844233579
-
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
-
DOI 10.1016/j.neuron.2004.11.005, PII S0896627304007202
-
Zimprich A, Biskup S, Leitner P et al.: Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607. (Pubitemid 39531225)
-
(2004)
Neuron
, vol.44
, Issue.4
, pp. 601-607
-
-
Zimprich, A.1
Biskup, S.2
Leitner, P.3
Lichtner, P.4
Farrer, M.5
Lincoln, S.6
Kachergus, J.7
Hulihan, M.8
Uitti, R.J.9
Calne, D.B.10
Stoessl, A.J.11
Pfeiffer, R.F.12
Patenge, N.13
Carbajal, I.C.14
Vieregge, P.15
Asmus, F.16
Muller-Myhsok, B.17
Dickson, D.W.18
Meitinger, T.19
Strom, T.M.20
Wszolek, Z.K.21
Gasser, T.22
more..
-
6
-
-
70549088602
-
Genome-wide association study reveals genetic risk underlying Parkinson's disease
-
Simon-Sanchez J, Schulte C, Bras JM et al.: Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009, 41:1308-1312.
-
(2009)
Nat Genet
, vol.41
, pp. 1308-1312
-
-
Simon-Sanchez, J.1
Schulte, C.2
Bras, J.M.3
-
7
-
-
70549084415
-
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
-
Satake W, Nakabayashi Y, Mizuta I et al.: Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009, 41:1303-1307.
-
(2009)
Nat Genet
, vol.41
, pp. 1303-1307
-
-
Satake, W.1
Nakabayashi, Y.2
Mizuta, I.3
-
8
-
-
68949125734
-
Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
-
Biskup S, West AB: Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease. Biochim Biophys Acta 2009, 1792:625-633.
-
(2009)
Biochim Biophys Acta
, vol.1792
, pp. 625-633
-
-
Biskup, S.1
West, A.B.2
-
9
-
-
50049104725
-
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: A case-control study
-
Healy DG, Falchi M, O'Sullivan SS et al.: Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008, 7:583-590.
-
(2008)
Lancet Neurol
, vol.7
, pp. 583-590
-
-
Healy, D.G.1
Falchi, M.2
O'Sullivan, S.S.3
-
10
-
-
32044432395
-
Biochemical and pathological characterization of Lrrk2
-
DOI 10.1002/ana.20791
-
Giasson BI, Covy JP, Bonini NM et al.: Biochemical and pathological characterization of Lrrk2. Annals of Neurology 2006, 59:315-322. (Pubitemid 43202485)
-
(2006)
Annals of Neurology
, vol.59
, Issue.2
, pp. 315-322
-
-
Giasson, B.I.1
Covy, J.P.2
Bonini, N.M.3
Hurtig, H.I.4
Farrer, M.J.5
Trojanowski, J.Q.6
Van Deerlin, V.M.7
-
11
-
-
32044466285
-
Lrrk2 and Lewy body disease
-
DOI 10.1002/ana.20731
-
Ross OA, Toft M, Whittle AJ et al.: Lrrk2 and Lewy body disease. Ann Neurol 2006, 59:388-393. (Pubitemid 43202496)
-
(2006)
Annals of Neurology
, vol.59
, Issue.2
, pp. 388-393
-
-
Ross, O.A.1
Toft, M.2
Whittle, A.J.3
Johnson, J.L.4
Papapetropoulos, S.5
Mash, D.C.6
Litvan, I.7
Gordon, M.F.8
Wszolek, Z.K.9
Farrer, M.J.10
Dickson, D.W.11
-
12
-
-
2342605968
-
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology
-
Wszolek ZK, Pfeiffer RF, Tsuboi Y et al.: Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004, 62:1619-1622. (Pubitemid 38608210)
-
(2004)
Neurology
, vol.62
, Issue.9
, pp. 1619-1622
-
-
Wszolek, Z.K.1
Pfeiffer, R.F.2
Tsuboi, Y.3
Uitti, R.J.4
McComb, R.D.5
Stoessl, A.J.6
Strongosky, A.J.7
Zimprich, A.8
Muller-Myhsok, B.9
Farrer, M.J.10
Gasser, T.11
Calne, D.B.12
Dickson, D.W.13
-
13
-
-
33646151866
-
LRRK2 in Parkinson's disease: Protein domains and functional insights
-
Mata IF, Wedemeyer WJ, Farrer MJ et al.: LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci 2006, 29:286-293.
-
(2006)
Trends Neurosci
, vol.29
, pp. 286-293
-
-
Mata, I.F.1
Wedemeyer, W.J.2
Farrer, M.J.3
-
14
-
-
77954197844
-
Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation
-
Berger Z, Smith KA, LaVoie MJ: Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation. Biochemistry 2010, 49:5511-5523.
-
(2010)
Biochemistry
, vol.49
, pp. 5511-5523
-
-
Berger, Z.1
Smith, K.A.2
Lavoie, M.J.3
-
15
-
-
47749114984
-
The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation
-
Greggio E, Zambrano I, Kaganovich A et al.: The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J Biol Chem 2008, 283:16906-16914.
-
(2008)
J Biol Chem
, vol.283
, pp. 16906-16914
-
-
Greggio, E.1
Zambrano, I.2
Kaganovich, A.3
-
16
-
-
40349101849
-
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase
-
DOI 10.1073/pnas.0709098105
-
Deng J, Lewis PA, Greggio E et al.: Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci U S A 2008, 105:1499-1504. (Pubitemid 351346543)
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.5
, pp. 1499-1504
-
-
Deng, J.1
Lewis, P.A.2
Greggio, E.3
Sluch, E.4
Beilina, A.5
Cookson, M.R.6
-
17
-
-
73649120624
-
Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization
-
Sen S, Webber PJ, West AB: Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. J Biol Chem 2009, 284:36346-36356.
-
(2009)
J Biol Chem
, vol.284
, pp. 36346-36356
-
-
Sen, S.1
Webber, P.J.2
West, A.B.3
-
18
-
-
77949514432
-
The WD40 domain is required for LRRK2 neurotoxicity
-
Jorgensen ND, Peng Y, Ho CCY et al.: The WD40 domain is required for LRRK2 neurotoxicity. PLoS One 2009, 4:e8463.
-
(2009)
PLoS One
, vol.4
-
-
Jorgensen, N.D.1
Peng, Y.2
Ho, C.C.Y.3
-
19
-
-
41649083587
-
Dynamic and redundant regulation of LRRK2 and LRRK1 expression
-
Biskup S, Moore D, Rea A et al.: Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMC Neurosci 2007, 8:102.
-
(2007)
BMC Neurosci
, vol.8
, pp. 102
-
-
Biskup, S.1
Moore, D.2
Rea, A.3
-
20
-
-
33845298032
-
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
-
DOI 10.1002/ana.21019
-
Biskup S, Moore DJ, Celsi F et al.: Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol 2006, 60:557-569. (Pubitemid 44871798)
-
(2006)
Annals of Neurology
, vol.60
, Issue.5
, pp. 557-569
-
-
Biskup, S.1
Moore, D.J.2
Celsi, F.3
Higashi, S.4
West, A.B.5
Andrabi, S.A.6
Kurkinen, K.7
Yu, S.-W.8
Savitt, J.M.9
Waldvogel, H.J.10
Faull, R.L.M.11
Emson, P.C.12
Torp, R.13
Ottersen, O.P.14
Dawson, T.M.15
Dawson, V.L.16
-
21
-
-
33645790701
-
LRRK2 expression linked to dopamine-innervated areas
-
Galter D, Westerlund M, Carmine A et al.: LRRK2 expression linked to dopamine-innervated areas. Ann Neurol 2006, 59:714-719.
-
(2006)
Ann Neurol
, vol.59
, pp. 714-719
-
-
Galter, D.1
Westerlund, M.2
Carmine, A.3
-
22
-
-
34250199013
-
Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain
-
DOI 10.1016/j.brainres.2007.04.034, PII S0006899307008657
-
Higashi S, Biskup S, West AB et al.: Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res 2007, 1155:208-219. (Pubitemid 46900930)
-
(2007)
Brain Research
, vol.1155
, Issue.1
, pp. 208-219
-
-
Higashi, S.1
Biskup, S.2
West, A.B.3
Trinkaus, D.4
Dawson, V.L.5
Faull, R.L.M.6
Waldvogel, H.J.7
Arai, H.8
Dawson, T.M.9
Moore, D.J.10
Emson, P.C.11
-
23
-
-
33845796537
-
Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain
-
DOI 10.1111/j.1471-4159.2006.04246.x
-
Higashi S, Moore DJ, Colebrooke RE et al.: Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain. J Neurochem 2007, 100:368-381. (Pubitemid 46010998)
-
(2007)
Journal of Neurochemistry
, vol.100
, Issue.2
, pp. 368-381
-
-
Higashi, S.1
Moore, D.J.2
Colebrooke, R.E.3
Biskup, S.4
Dawson, V.L.5
Arai, H.6
Dawson, T.M.7
Emson, P.C.8
-
24
-
-
40949145205
-
Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease
-
Westerlund M, Belin AC, Anvret A et al.: Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease. Neuroscience 2008, 152:429-436.
-
(2008)
Neuroscience
, vol.152
, pp. 429-436
-
-
Westerlund, M.1
Belin, A.C.2
Anvret, A.3
-
25
-
-
79951534656
-
LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool
-
Piccoli G, Condliffe SB, Bauer M et al.: LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J Neurosci 2011, 31:2225-2237.
-
(2011)
J Neurosci
, vol.31
, pp. 2225-2237
-
-
Piccoli, G.1
Condliffe, S.B.2
Bauer, M.3
-
26
-
-
84863294414
-
Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway
-
Tong Y, Giaime E, Yamaguchi H et al.: Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway. Mol Neurodegener 2012, 7:2.
-
(2012)
Mol Neurodegener
, vol.7
, pp. 2
-
-
Tong, Y.1
Giaime, E.2
Yamaguchi, H.3
-
27
-
-
77953090478
-
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice
-
Tong Y, Yamaguchi H, Giaime E et al.: Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci U S A 2010, 107:9879-9884.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 9879-9884
-
-
Tong, Y.1
Yamaguchi, H.2
Giaime, E.3
-
28
-
-
80053968304
-
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
-
Herzig MC, Kolly C, Persohn E et al.: LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet 2011, 20:4209-4223.
-
(2011)
Hum Mol Genet
, vol.20
, pp. 4209-4223
-
-
Herzig, M.C.1
Kolly, C.2
Persohn, E.3
-
29
-
-
33646146878
-
Anatomical localization of leucine-rich repeat kinase 2 in mouse brain
-
DOI 10.1016/j.neuroscience.2006.01.017, PII S0306452206001175
-
Melrose H, Lincoln S, Tyndall G et al.: Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience 2006, 139:791-794. (Pubitemid 44308089)
-
(2006)
Neuroscience
, vol.139
, Issue.3
, pp. 791-794
-
-
Melrose, H.1
Lincoln, S.2
Tyndall, G.3
Dickson, D.4
Farrer, M.5
-
30
-
-
70349991886
-
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model
-
Alegre-Abarrategui J, Christian H, Lufino MMP et al.: LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 2009, 18:4022-4034.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 4022-4034
-
-
Alegre-Abarrategui, J.1
Christian, H.2
Lufino, M.M.P.3
-
31
-
-
34247098407
-
Leucine-rich repeat kinase 2 associates with lipid rafts
-
DOI 10.1093/hmg/ddm013
-
Hatano T, Kubo S, Imai S et al.: Leucine-rich repeat kinase 2 associates with lipid rafts. Hum Mol Genet 2007, 16:678-690. (Pubitemid 46585667)
-
(2007)
Human Molecular Genetics
, vol.16
, Issue.6
, pp. 678-690
-
-
Hatano, T.1
Kubo, S.-I.2
Imai, S.3
Maeda, M.4
Ishikawa, K.5
Mizuno, Y.6
Hattori, N.7
-
32
-
-
84863241584
-
Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning
-
Dec 30 Epub
-
Dodson MW, Zhang T, Jiang C et al.: Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning. Hum Mol Genet 2011, Dec 30, Epub.
-
(2011)
Hum Mol Genet
-
-
Dodson, M.W.1
Zhang, T.2
Jiang, C.3
-
33
-
-
65649142038
-
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro
-
Gloeckner CJ, Schumacher A, Boldt K, Ueffing M: The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro. J Neurochem 2009, 109:959-968.
-
(2009)
J Neurochem
, vol.109
, pp. 959-968
-
-
Gloeckner, C.J.1
Schumacher, A.2
Boldt, K.3
Ueffing, M.4
-
34
-
-
77349113121
-
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2
-
Hsu CH, Chan D, Greggio E et al.: MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2. J Neurochem 2010, 112:1593-1604.
-
(2010)
J Neurochem
, vol.112
, pp. 1593-1604
-
-
Hsu, C.H.1
Chan, D.2
Greggio, E.3
-
35
-
-
77951898652
-
Leucinerich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway
-
Carballo-Carbajal I, Weber-Endress S, Rovelli G et al.: Leucinerich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway. Cell Signal 2010, 22:821-827.
-
(2010)
Cell Signal
, vol.22
, pp. 821-827
-
-
Carballo-Carbajal, I.1
Weber-Endress, S.2
Rovelli, G.3
-
36
-
-
33846562487
-
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
-
DOI 10.1093/hmg/ddl471
-
West AB, Moore DJ, Choi C et al.: Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet 2007, 16:223-232. (Pubitemid 46179004)
-
(2007)
Human Molecular Genetics
, vol.16
, Issue.2
, pp. 223-232
-
-
West, A.B.1
Moore, D.J.2
Choi, C.3
Andrabi, S.A.4
Li, X.5
Dikeman, D.6
Biskup, S.7
Zhang, Z.8
Lim, K.-L.9
Dawson, V.L.10
Dawson, T.M.11
-
37
-
-
34447118788
-
LRRK2 phosphorylates moesin at threonine-558: Characterization of how Parkinson's disease mutants affect kinase activity
-
DOI 10.1042/BJ20070209
-
Jaleel M, Nichols RJ, Deak M et al.: LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J 2007, 405:307-317. (Pubitemid 47075166)
-
(2007)
Biochemical Journal
, vol.405
, Issue.2
, pp. 307-317
-
-
Jaleel, M.1
Nichols, R.J.2
Deak, M.3
Campbell, D.G.4
Gillardon, F.5
Knebel, A.6
Alessi, D.R.7
-
38
-
-
28044460070
-
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
-
DOI 10.1073/pnas.0507360102
-
West AB, Moore DJ, Biskup S et al.: Parkinson's diseaseassociated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 2005, 102:16842-16847. (Pubitemid 41688864)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.46
, pp. 16842-16847
-
-
West, A.B.1
Moore, D.J.2
Biskup, S.3
Bugayenko, A.4
Smith, W.W.5
Ross, C.A.6
Dawson, V.L.7
Dawson, T.M.8
-
39
-
-
70350653779
-
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
-
Nichols RJ, Dzamko N, Hutti JE et al.: Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. Biochem J 2009, 424:47-60.
-
(2009)
Biochem J
, vol.424
, pp. 47-60
-
-
Nichols, R.J.1
Dzamko, N.2
Hutti, J.E.3
-
40
-
-
68949218403
-
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - A point of convergence in Parkinsonian neurodegeneration?
-
Gillardon F: Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration? J Neurochem 2009, 110:1514-1522.
-
(2009)
J Neurochem
, vol.110
, pp. 1514-1522
-
-
Gillardon, F.1
-
41
-
-
77956521263
-
Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila
-
Kanao T, Venderova K, Park DS et al.: Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila. Hum Mol Genet 2010, 19:3747-3758.
-
(2010)
Hum Mol Genet
, vol.19
, pp. 3747-3758
-
-
Kanao, T.1
Venderova, K.2
Park, D.S.3
-
42
-
-
51949090816
-
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
-
Imai Y, Gehrke S, Wang HQ et al.: Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 2008, 27:2432-2443.
-
(2008)
EMBO J
, vol.27
, pp. 2432-2443
-
-
Imai, Y.1
Gehrke, S.2
Wang, H.Q.3
-
43
-
-
67651008224
-
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
-
Qing H, Wong W, McGeer EG, McGeer PL: Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. Biochem Biophys Res Commun 2009, 387:149-152.
-
(2009)
Biochem Biophys Res Commun
, vol.387
, pp. 149-152
-
-
Qing, H.1
Wong, W.2
McGeer, E.G.3
McGeer, P.L.4
-
44
-
-
77957377567
-
LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of Tau by recruiting autoactivated GSK3{beta}
-
Lin C-H, Tsai P-I, Wu R-M, Chien C-T: LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of Tau by recruiting autoactivated GSK3{beta}. J Neurosci 2010, 30:13138-13149.
-
(2010)
J Neurosci
, vol.30
, pp. 13138-13149
-
-
Lin, C.-H.1
Tsai, P.-I.2
Wu, R.-M.3
Chien, C.-T.4
-
45
-
-
77649328234
-
The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4EBP compared to autophosphorylation
-
Kumar A, Greggio E, Beilina A et al.: The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4EBP compared to autophosphorylation. PLoS One 2010, 5:e8730.
-
(2010)
PLoS One
, vol.5
-
-
Kumar, A.1
Greggio, E.2
Beilina, A.3
-
46
-
-
77950631558
-
Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the Nterminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2
-
Gloeckner CJ, Boldt K, von Zweydorf F et al.: Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the Nterminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2. J Proteome Res 2010, 9:1738-1745.
-
(2010)
J Proteome Res
, vol.9
, pp. 1738-1745
-
-
Gloeckner, C.J.1
Boldt, K.2
Von Zweydorf, F.3
-
47
-
-
70449732284
-
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites
-
Greggio E, Taymans JM, Zhen EY et al.: The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites. Biochem Biophys Res Commun 2009, 389:449-454.
-
(2009)
Biochem Biophys Res Commun
, vol.389
, pp. 449-454
-
-
Greggio, E.1
Taymans, J.M.2
Zhen, E.Y.3
-
48
-
-
84860389765
-
Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities
-
Webber PJ, Smith AD, Sen S et al.: Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities. J Mol Biol 2011, 412:94-110.
-
(2011)
J Mol Biol
, vol.412
, pp. 94-110
-
-
Webber, P.J.1
Smith, A.D.2
Sen, S.3
-
49
-
-
72749105819
-
Identification of the autophosphorylation sites of LRRK2
-
Kamikawaji S, Ito G, Iwatsubo T: Identification of the autophosphorylation sites of LRRK2. Biochemistry 2009, 48:10963-10975.
-
(2009)
Biochemistry
, vol.48
, pp. 10963-10975
-
-
Kamikawaji, S.1
Ito, G.2
Iwatsubo, T.3
-
50
-
-
34548621385
-
Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants
-
DOI 10.1111/j.1471-4159.2007.04743.x
-
Li X, Tan YC, Poulose S et al.: Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J Neurochem 2007, 103:238-247. (Pubitemid 47404210)
-
(2007)
Journal of Neurochemistry
, vol.103
, Issue.1
, pp. 238-247
-
-
Li, X.1
Tan, Y.-C.2
Poulose, S.3
Olanow, C.W.4
Huang, X.-Y.5
Yue, Z.6
-
51
-
-
34247468302
-
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
-
DOI 10.1016/j.bbrc.2007.04.006, PII S0006291X07006894
-
Lewis PA, Greggio E, Beilina A et al.: The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem Biophys Res Commun 2007, 357:668-671. (Pubitemid 46653831)
-
(2007)
Biochemical and Biophysical Research Communications
, vol.357
, Issue.3
, pp. 668-671
-
-
Lewis, P.A.1
Greggio, E.2
Beilina, A.3
Jain, S.4
Baker, A.5
Cookson, M.R.6
-
52
-
-
33846818834
-
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
-
DOI 10.1021/bi061960m
-
Ito G, Okai T, Fujino G et al.: GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease. Biochemistry 2007, 46:1380-1388. (Pubitemid 46208485)
-
(2007)
Biochemistry
, vol.46
, Issue.5
, pp. 1380-1388
-
-
Ito, G.1
Okai, T.2
Fujino, G.3
Takeda, K.4
Ichijo, H.5
Katada, T.6
Iwatsubo, T.7
-
53
-
-
33748993710
-
Kinase activity of mutant LRRK2 mediates neuronal toxicity
-
DOI 10.1038/nn1776, PII NN1776
-
SmithWW, Pei Z, Jiang H et al.: Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 2006, 9:1231-1233. (Pubitemid 44454261)
-
(2006)
Nature Neuroscience
, vol.9
, Issue.10
, pp. 1231-1233
-
-
Smith, W.W.1
Pei, Z.2
Jiang, H.3
Dawson, V.L.4
Dawson, T.M.5
Ross, C.A.6
-
54
-
-
80051611506
-
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding
-
Taymans JM, Vancraenenbroeck R, Ollikainen P et al.: LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding. PLoS One 2011, 6:e23207.
-
(2011)
PLoS One
, vol.6
-
-
Taymans, J.M.1
Vancraenenbroeck, R.2
Ollikainen, P.3
-
55
-
-
78149446290
-
ARHGEF7 (Beta- PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2
-
Haebig K, Gloeckner CJ, Miralles MG et al.: ARHGEF7 (Beta- PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2. PLoS One 2010, 5:e13762.
-
(2010)
PLoS One
, vol.5
-
-
Haebig, K.1
Gloeckner, C.J.2
Miralles, M.G.3
-
56
-
-
84859187983
-
GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1
-
Stafa K, Trancikova A, Webber P et al.: GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1. PLoS Genet 2012, 8:e1002527.
-
(2012)
PLoS Genet
, vol.8
-
-
Stafa, K.1
Trancikova, A.2
Webber, P.3
-
57
-
-
47249084622
-
The biology and pathobiology of LRRK2: Implications for Parkinson's disease
-
Moore DJ: The biology and pathobiology of LRRK2: Implications for Parkinson's disease. Parkinsonism Relat Disord 2008, 14:S92-S98.
-
(2008)
Parkinsonism Relat Disord
, vol.14
-
-
Moore, D.J.1
-
58
-
-
31144443248
-
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
-
DOI 10.1093/hmg/ddi439
-
Gloeckner CJ, Kinkl N, Schumacher A et al.: The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 2006, 15:223-232. (Pubitemid 43125977)
-
(2006)
Human Molecular Genetics
, vol.15
, Issue.2
, pp. 223-232
-
-
Gloeckner, C.J.1
Kinkl, N.2
Schumacher, A.3
Braun, R.J.4
O'Neill, E.5
Meitinger, T.6
Kolch, W.7
Prokisch, H.8
Ueffing, M.9
-
59
-
-
77953395313
-
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: Three questions
-
Greggio E, Cookson MR: Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro 2009, 1.
-
(2009)
ASN Neuro
, vol.1
-
-
Greggio, E.1
Cookson, M.R.2
-
60
-
-
77952391573
-
GTPase activity plays a key role in the pathobiology of LRRK2
-
Xiong Y, Coombes CE, Kilaru A et al.: GTPase activity plays a key role in the pathobiology of LRRK2. PLoS Genet 2010, 6: e1000902.
-
(2010)
PLoS Genet
, vol.6
-
-
Xiong, Y.1
Coombes, C.E.2
Kilaru, A.3
-
61
-
-
78650685500
-
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
-
Daniels V, Vancraenenbroeck R, Law BM et al.: Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant. J Neurochem 2011, 116:304-315.
-
(2011)
J Neurochem
, vol.116
, pp. 304-315
-
-
Daniels, V.1
Vancraenenbroeck, R.2
Law, B.M.3
-
62
-
-
29444437871
-
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
-
DOI 10.1073/pnas.0508052102
-
Smith WW, Pei Z, Jiang H et al.: Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci U S A 2005, 102:18676-18681. (Pubitemid 43011285)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.51
, pp. 18676-18681
-
-
Smith, W.W.1
Pei, Z.2
Jiang, H.3
Moore, D.J.4
Liang, Y.5
West, A.B.6
Dawson, V.L.7
Dawson, T.M.8
Ross, C.A.9
-
63
-
-
80054977424
-
Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons
-
Ramsden N, Perrin J, Ren Z et al.: Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chem Biol 2011, 6:1021-1028.
-
(2011)
ACS Chem Biol
, vol.6
, pp. 1021-1028
-
-
Ramsden, N.1
Perrin, J.2
Ren, Z.3
-
64
-
-
77956441086
-
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
-
Lee BD, Shin J-H, VanKampen J et al.: Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat Med 2010, 16:998-1000.
-
(2010)
Nat Med
, vol.16
, pp. 998-1000
-
-
Lee, B.D.1
Shin, J.-H.2
Vankampen, J.3
-
65
-
-
33746267531
-
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
-
DOI 10.1016/j.nbd.2006.04.001, PII S0969996106000714
-
Greggio E, Jain S, Kingsbury A et al.: Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 2006, 23:329-341. (Pubitemid 44097032)
-
(2006)
Neurobiology of Disease
, vol.23
, Issue.2
, pp. 329-341
-
-
Greggio, E.1
Jain, S.2
Kingsbury, A.3
Bandopadhyay, R.4
Lewis, P.5
Kaganovich, A.6
Van Der Brug, M.P.7
Beilina, A.8
Blackinton, J.9
Thomas, K.J.10
Ahmad, R.11
Miller, D.W.12
Kesavapany, S.13
Singleton, A.14
Lees, A.15
Harvey, R.J.16
Harvey, K.17
Cookson, M.R.18
-
66
-
-
40649108102
-
A Drosophila model for LRRK2-linked parkinsonism
-
DOI 10.1073/pnas.0708452105
-
Liu Z, Wang X, Yu Yet al.: A Drosophila model for LRRK2-linked parkinsonism. Proc Natl Acad Sci U S A 2008, 105:2693-2698. (Pubitemid 351520575)
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.7
, pp. 2693-2698
-
-
Liu, Z.1
Wang, X.2
Yu, Y.3
Li, X.4
Wang, T.5
Jiang, H.6
Ren, Q.7
Jiao, Y.8
Sawa, A.9
Moran, T.10
Ross, C.A.11
Montell, C.12
Smith, W.W.13
-
67
-
-
80053152848
-
Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
-
Liu Z, Hamamichi S, Lee BD et al.: Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models. Hum Mol Genet 2011, 20:3933-3942.
-
(2011)
Hum Mol Genet
, vol.20
, pp. 3933-3942
-
-
Liu, Z.1
Hamamichi, S.2
Lee, B.D.3
-
68
-
-
70349103837
-
Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila
-
Ng CH, Mok SZ, Koh C et al.: Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. J Neurosci 2009, 29:11257-11262.
-
(2009)
J Neurosci
, vol.29
, pp. 11257-11262
-
-
Ng, C.H.1
Mok, S.Z.2
Koh, C.3
-
69
-
-
78751522558
-
A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2
-
Dusonchet J, Kochubey O, Stafa K et al.: A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2. J Neurosci 2011, 31:907-912.
-
(2011)
J Neurosci
, vol.31
, pp. 907-912
-
-
Dusonchet, J.1
Kochubey, O.2
Stafa, K.3
-
70
-
-
79952918505
-
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
-
Deng X, Dzamko N, Prescott A et al.: Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2. Nat Chem Biol 2011, 7:203-205.
-
(2011)
Nat Chem Biol
, vol.7
, pp. 203-205
-
-
Deng, X.1
Dzamko, N.2
Prescott, A.3
-
71
-
-
79953758383
-
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing g2019s mutant LRRK2
-
Ramonet D, Daher JPL, Lin BM et al.: Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2. PLoS One 2011, 6:e18568.
-
(2011)
PLoS One
, vol.6
-
-
Ramonet, D.1
Daher, J.P.L.2
Lin, B.M.3
-
72
-
-
67649813448
-
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease
-
Li Y, Liu W, Oo TF et al.: Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 2009, 12:826-828.
-
(2009)
Nat Neurosci
, vol.12
, pp. 826-828
-
-
Li, Y.1
Liu, W.2
Oo, T.F.3
-
73
-
-
76149134717
-
Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S
-
Li X, Patel JC, Wang J et al.: Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J Neurosci 2010, 1788-1797.
-
(2010)
J Neurosci
, pp. 1788-1797
-
-
Li, X.1
Patel, J.C.2
Wang, J.3
-
74
-
-
77957794336
-
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenicmice
-
Melrose HL, Dächsel JC, Behrouz B et al.: Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenicmice.Neurobiol Dis 2010, 40:503-517.
-
(2010)
Neurobiol Dis
, vol.40
, pp. 503-517
-
-
Melrose, H.L.1
Dächsel, J.C.2
Behrouz, B.3
-
75
-
-
70149124508
-
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
-
Tong Y, Pisani A, Martella G et al.: R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc Natl Acad Sci U S A 2009, 106:14622-14627.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 14622-14627
-
-
Tong, Y.1
Pisani, A.2
Martella, G.3
-
76
-
-
46549089664
-
LRRK2 regulates synaptic vesicle endocytosis
-
Shin N, Jeong H, Kwon J et al.: LRRK2 regulates synaptic vesicle endocytosis. Exp Cell Res 2008, 314:2055-2065.
-
(2008)
Exp Cell Res
, vol.314
, pp. 2055-2065
-
-
Shin, N.1
Jeong, H.2
Kwon, J.3
-
77
-
-
33947663512
-
LRK-1, a C. elegans PARK8-Related Kinase, Regulates Axonal-Dendritic Polarity of SV Proteins
-
DOI 10.1016/j.cub.2007.01.074, PII S0960982207009931
-
Sakaguchi-Nakashima A, Meir JY, Jin Y et al.: LRK-1, a C. elegans PARK8-Related Kinase, Regulates Axonal-Dendritic Polarity of SV Proteins. Curr Biol 2007, 17:592-598. (Pubitemid 46497793)
-
(2007)
Current Biology
, vol.17
, Issue.7
, pp. 592-598
-
-
Sakaguchi-Nakashima, A.1
Meir, J.Y.2
Jin, Y.3
Matsumoto, K.4
Hisamoto, N.5
-
78
-
-
34447294546
-
Apoptotic mechanisms in mutant LRRK2-mediated cell death
-
DOI 10.1093/hmg/ddm080
-
Iaccarino C, Crosio C, Vitale C et al.: Apoptotic mechanisms in mutant LRRK2-mediated cell death. Hum Mol Genet 2007, 16:1319-1326. (Pubitemid 47055127)
-
(2007)
Human Molecular Genetics
, vol.16
, Issue.11
, pp. 1319-1326
-
-
Laccarino, C.1
Crosio, C.2
Vitale, C.3
Sanna, G.4
Carri, M.T.5
Barone, P.6
-
79
-
-
33751256567
-
The familial Parkinsonism gene LRRK2 regulates neurite process morphology
-
DOI 10.1016/j.neuron.2006.10.008, PII S0896627306008075
-
MacLeod D, Dowman J, Hammond R et al.: The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006, 52:587-593. (Pubitemid 44781171)
-
(2006)
Neuron
, vol.52
, Issue.4
, pp. 587-593
-
-
MacLeod, D.1
Dowman, J.2
Hammond, R.3
Leete, T.4
Inoue, K.5
Abeliovich, A.6
-
80
-
-
59649089328
-
The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via fasassociated protein with death domain and caspase-8 in a cellular model of neurodegeneration
-
Ho CC-Y, Rideout HJ, Ribe E et al.: The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via fasassociated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J Neurosci 2009, 29:1011-1016.
-
(2009)
J Neurosci
, vol.29
, pp. 1011-1016
-
-
Cc-Y, H.1
Rideout, H.J.2
Ribe, E.3
-
81
-
-
65249107203
-
Microtubule assembly, organization and dynamics in axons and dendrites
-
Conde C, Caceres A: Microtubule assembly, organization and dynamics in axons and dendrites. Nat Rev Neurosci 2009, 10:319-332.
-
(2009)
Nat Rev Neurosci
, vol.10
, pp. 319-332
-
-
Conde, C.1
Caceres, A.2
-
82
-
-
39549117093
-
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
-
DOI 10.1111/j.1471-4159.2008.05217.x
-
Plowey ED, Cherra SJ, Liu Y-J, Chu CT: Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 2008, 105:1048-1056. (Pubitemid 351565713)
-
(2008)
Journal of Neurochemistry
, vol.105
, Issue.3
, pp. 1048-1056
-
-
Plowey, E.D.1
Cherra III, S.J.2
Liu, Y.-J.3
Chu, C.T.4
-
83
-
-
70449377127
-
Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis
-
Parisiadou L, Xie C, Cho HJ et al.: Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 2009, 29:13971-13980.
-
(2009)
J Neurosci
, vol.29
, pp. 13971-13980
-
-
Parisiadou, L.1
Xie, C.2
Cho, H.J.3
-
84
-
-
79955544006
-
Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2)
-
Chan D, Citro A, Cordy JM et al.: Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem 2011, 286:16140-16149.
-
(2011)
J Biol Chem
, vol.286
, pp. 16140-16149
-
-
Chan, D.1
Citro, A.2
Cordy, J.M.3
-
85
-
-
45549085874
-
The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules
-
DOI 10.1002/jnr.21622
-
Gandhi PN, Wang X, Zhu X et al.: The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J Neurosci Res 2008, 86:1711-1720. (Pubitemid 351859422)
-
(2008)
Journal of Neuroscience Research
, vol.86
, Issue.8
, pp. 1711-1720
-
-
Gandhi, P.N.1
Wang, X.2
Zhu, X.3
Chen, S.G.4
Wilson-Delfosse, A.L.5
-
86
-
-
72149087091
-
Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant [alpha]-synuclein
-
Lin X, Parisiadou L, Gu X-L et al.: Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease- Related Mutant [alpha]-synuclein. Neuron 2009, 64:807-827.
-
(2009)
Neuron
, vol.64
, pp. 807-827
-
-
Lin, X.1
Parisiadou, L.2
Gu, X.-L.3
-
87
-
-
84863012282
-
LRRK2 Parkinson disease mutations enhance its microtubule association
-
Kett LR, Boassa D, Ho CC-Y et al.: LRRK2 Parkinson disease mutations enhance its microtubule association. Hum Mol Genet 2012, 21:890-899.
-
(2012)
Hum Mol Genet
, vol.21
, pp. 890-899
-
-
Kett, L.R.1
Boassa, D.2
Cc-Y, H.3
-
88
-
-
33750308194
-
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
-
DOI 10.1212/01.wnl.0000240220.33950.0c, PII 0000611420061024000046
-
Rajput A, Dickson DW, Robinson CA et al.: Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 2006, 67:1506-1508. (Pubitemid 44632090)
-
(2006)
Neurology
, vol.67
, Issue.8
, pp. 1506-1508
-
-
Rajput, A.1
Dickson, D.W.2
Robinson, C.A.3
Ross, O.A.4
Dachsel, J.C.5
Lincoln, S.J.6
Cobb, S.A.7
Rajput, M.L.8
Farrer, M.J.9
-
89
-
-
70349574622
-
Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease
-
Higashi S, Moore DJ, Yamamoto R et al.: Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease. J Neuropathol Exp Neurol 2009, 68:994-1005.
-
(2009)
J Neuropathol Exp Neurol
, vol.68
, pp. 994-1005
-
-
Higashi, S.1
Moore, D.J.2
Yamamoto, R.3
-
90
-
-
80052324528
-
The Parkinson's disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activity
-
Lichtenberg M, Mansilla A, Zecchini VR et al.: The Parkinson's disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activity. Cell Death Dis 2011, 2:e196.
-
(2011)
Cell Death Dis
, vol.2
-
-
Lichtenberg, M.1
Mansilla, A.2
Zecchini, V.R.3
-
91
-
-
84862907943
-
Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP
-
Gómez-Suaga P, Luzón-Toro B, Churamani D et al.: Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP. Hum Mol Genet 2011, 21:511-525.
-
(2011)
Hum Mol Genet
, vol.21
, pp. 511-525
-
-
Gómez-Suaga, P.1
Luzón-Toro, B.2
Churamani, D.3
-
92
-
-
84861230655
-
Mitochondrial dysfunction in genetic animal models of Parkinson's disease
-
Oct 4 Epub
-
Trancikova A, Tsika E, Moore DJ: Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease. Antioxid Redox Signal 2011, Oct 4, Epub.
-
(2011)
Antioxid Redox Signal
-
-
Trancikova, A.1
Tsika, E.2
Moore, D.J.3
-
93
-
-
78650025189
-
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
-
Mortiboys H, Johansen KK, Aasly JO, Bandmann O: Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. Neurology 2010, 75:2017-2020.
-
(2010)
Neurology
, vol.75
, pp. 2017-2020
-
-
Mortiboys, H.1
Johansen, K.K.2
Aasly, J.O.3
Bandmann, O.4
-
94
-
-
84859259002
-
LRRK2 Regulates Mitochondrial Dynamics and Function through Direct Interaction with DLP1
-
Jan 6 Epub
-
Wang X, Yan MH, Fujioka H et al.: LRRK2 Regulates Mitochondrial Dynamics and Function through Direct Interaction with DLP1. Hum Mol Genet 2012, Jan 6, Epub.
-
(2012)
Hum Mol Genet
-
-
Wang, X.1
Yan, M.H.2
Fujioka, H.3
|